Francesca Barone
2023
In 2023, Francesca Barone earned a total compensation of $706.9K as Chief Scientific Officer at Candel Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $80,560 |
---|---|
Option Awards | $89,577 |
Salary | $413,005 |
Stock Awards | $110,534 |
Other | $13,200 |
Total | $706,876 |
Barone received $413K in salary, accounting for 58% of the total pay in 2023.
Barone also received $80.6K in non-equity incentive plan, $89.6K in option awards, $110.5K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Francesca Barone's compensation ranked 1,588th out of 2,918 executives tracked by ExecPay. In other words, Barone earned more than 45.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,588 | 46th |
Manufacturing | 935 | 42nd |
Chemicals And Allied Products | 599 | 34th |
Drugs | 583 | 33rd |
Biological Products, Except Diagnostic Substances | 159 | 25th |
Barone's colleagues
We found two more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2023.